iHeart DepCare Tool for Depression
(iHeart_2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new tool called iHeart DepCare to help treat depression in people with coronary heart disease (CHD). The study aims to determine if this tool, combined with additional support, can improve depression care compared to the usual treatment approach. Participants will be randomly assigned to either receive only depression screening or use the iHeart DepCare tool with motivational support. Potential participants include CHD patients who have experienced depression symptoms and are seeing a primary care doctor or cardiologist at Columbia. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance depression care for CHD patients.
What prior data suggests that the iHeart DepCare tool is safe for use in depression treatment among CHD patients?
Research has shown that the iHeart DepCare tool has been used in various studies to help manage depression, particularly for heart disease patients. This tool includes a questionnaire and uses easy-to-understand visuals to facilitate decision-making between patients and doctors. In past studies, patients used it without encountering major safety issues.
The tool aims to improve treatment for people with depression and presents no known risks. In the studies conducted, both patients and healthcare providers found it helpful. There have been no significant reports of harmful effects from using the iHeart DepCare tool.
Overall, current research considers the tool safe. It focuses on enhancing patient involvement and treatment for depression, with no serious side effects reported in the studies reviewed so far.12345Why are researchers excited about this trial?
Researchers are excited about the iHeart DepCare tool because it integrates motivational interviewing and personalized support into depression management for patients with heart conditions. Unlike traditional treatments that often involve medication or therapy alone, this tool provides a holistic approach by incorporating patient preferences and ongoing support from healthcare providers. This personalized method could lead to better engagement and outcomes for patients, making it a promising addition to depression care in a cardiology setting.
What evidence suggests that the iHeart DepCare tool is effective for depression in CHD patients?
Research has shown that the iHeart DepCare tool, available to participants in this trial, may help reduce depression symptoms in people with coronary heart disease (CHD). This tool includes a simple questionnaire to check for depression and a plan to manage it. Studies have found that using iHeart DepCare helps patients better understand and engage with their treatment options. Over time, patients who used the tool reported feeling less depressed. It also aids healthcare providers in referring patients for additional treatment when needed. Early results suggest that iHeart DepCare improves depression care for both patients and healthcare providers in everyday settings.12678
Who Is on the Research Team?
Nathalie Moise, MD, MS, FAHA
Principal Investigator
Columbia University
Are You a Good Fit for This Trial?
This trial is for coronary heart disease patients at Columbia University Irving Medical Center who show signs of depression. They must be due for primary care or cardiology appointments and willing to use the iHeart DepCare tool if randomized to do so.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the iHeart DepCare tool and motivational interviewing support
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- iHeart DepCare tool
Trial Overview
The study tests if the iHeart DepCare tool, along with support from Clinic Navigators, improves adoption of depression treatment in cardiac patients. It compares usual care against using this tool, focusing on how well it helps manage depression.
How Is the Trial Designed?
2
Treatment groups
Active Control
As part of a Quality Improvement Initiative, navigators and clinical staff call patients to screen patients for depression using the Patient Health Questionnaire (PHQ)-2 followed by the PHQ-9 in advance of scheduled office visits with cardiologists or primary care clinicians and enter results into Epic for providers to view during their visits and refer and manage depression at their discretion. Patients will receive the clinic's mental health informational resource.
As part of a Quality Improvement Initiative, navigators and clinical staff call patients to screen patients for depression using the Patient Health Questionnaire (PHQ)-2 followed by the PHQ-9 in advance of scheduled office visits with cardiologists or primary care clinicians and enter results into Epic for providers to view during their visits and refer and manage depression at their discretion. Eligible patients who screen positive for depression (PHQ-9 ≥8) are administered the Heart DepCare tool along with motivational, technical and navigational support per patient preference. Clinical and mental health providers are sent the patient's treatment preferences via EPIC.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
Citations
A Patient Activation Approach to Implementing Depression ...
The research now expands to test the real-world effectiveness of the iHeart DepCare tool in cardiology and primary care settings. Official ...
Implementing depression treatment for cardiac populations ...
The primary effectiveness outcome is change in depressive symptoms from baseline to follow-up during the post-implementation period compared to pre- ...
Implementing depression treatment for cardiac populations in ...
The IHEART DEPCARE Trial is the first hybrid type II effectiveness-implementation trial to examine the effect of a brief, theory-informed eSDM and patient ...
4.
columbiacardiology.org
columbiacardiology.org/research/research-centers-and-programs/center-behavioral-cardiovascular-health/our-research/columbia-roybal-center-fearless-behavior-change/our-research/behavioral-rctsBehavioral RCTs | Division of Cardiology
Here, we will refine and evaluate a multi-component iHeart DepCare intervention in real world settings by conducting a provider-level cluster randomized control ...
Increasing Uptake of Depression Screening and Treatment ...
The multilingual patient activation/persuasion eSDM tool (iHeart DepCare) includes a screening questionnaire and depression profile ...
Increasing Uptake of Depression Screening and Treatment ...
The final multicomponent strategy (iHeart DepCare) for promoting depression screening/treatment included problem-solving meetings with clinic staff (system); ...
Increasing uptake of depression screening and treatment ...
The multilingual patient activation/persuasion eSDM tool (iHeart DepCare) includes a screening questionnaire and depression profile, infographics and a script ...
An IT Approach to Implementing Depression Treatment in ...
The specific aim is to determine whether an electronic shared decision making (eSDM) and behavioral activation tool improves depressive symptoms and treatment ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.